Approval · Notice of Compliance 9186 · 2007
ZEMPLAR: Notice of Compliance 9186
Issued November 22, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9186
- Date
- November 22, 2007
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: capsules (with associated indication)
- Therapeutic class
- Vitamin D Analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEMPLAR | 02302497 | — |
| ZEMPLAR | 02302500 | — |
| ZEMPLAR | 02302519 | — |
Medicinal ingredients
- PARICALCITOL 1 MCG per CAP
- PARICALCITOL 2 MCG per CAP
- PARICALCITOL 4 MCG per CAP